The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ECOG-ACRIN 5508: Pemetrexed, bevacizumab or the combination as maintenance therapy for advanced non-squamous NSCLC.
 
Suresh S. Ramalingam
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly/ImClone; Loxo; Merck; Nektar; Takeda; Tesaro
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Merck (Inst); Merck (Inst); Pfizer (Inst); Takeda (Inst); Vertex (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Suzanne Eleanor Dahlberg
Consulting or Advisory Role - AstraZeneca
Patents, Royalties, Other Intellectual Property - Patent pending for a statistical model assessing tumor growth (Inst)
 
Chandra Prakash Belani
Consulting or Advisory Role - Genentech/Roche; Janssen; Takeda
Research Funding - EMD Serono (Inst); Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Janssen; Takeda
 
Joel N. Saltzman
Stock and Other Ownership Interests - novartis; Roche
Consulting or Advisory Role - Lilly; Lilly
 
Gopakumar S. Nambudiri
No Relationships to Disclose
 
John McCann
Research Funding - Boehringer Ingelheim
 
Jerome D. Winegarden
No Relationships to Disclose
 
Mohammed Azher Kassem
No Relationships to Disclose
 
Mohamed K. Mohamed
Honoraria - AstraZeneca; Bristol-Myers Squibb; Lilly; Merck
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Lilly; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Lilly; Merck
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Lilly; Merck
 
Jan M. Rothman
No Relationships to Disclose
 
Alan P. Lyss
No Relationships to Disclose
 
Leora Horn
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; EMD Serono; Genentech; Incyte; Janssen; Lilly; Merck; Tesaro; Xcovery
Research Funding - Boehringer Ingelheim (Inst); Xcovery (Inst)
Other Relationship - Boehringer Ingelheim; Bristol-Myers Squibb
 
Tom Stinchcombe
Consulting or Advisory Role - AstraZeneca; G1 Therapeutics; G1 Therapeutics; Genentech/Roche; Novartis; Regeneron; Takeda
Research Funding - AstraZeneca (Inst); Blueprint Medicines (Inst); Genentech/Roche (Inst); Merck (Inst); Takeda (Inst)
 
Joan H. Schiller
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Lung Cancer Research Foundation
Research Funding - Genentech (Inst); Merck (Inst)
Other Relationship - Free to Breathe